Angelos M. Stergiou
About Angelos M. Stergiou
Angelos M. Stergiou is the President and CEO of a biotechnology firm, holding a Doctor of Medicine and a Doctor of Science (honoris causa). He has extensive experience in pharmaceutical and biotechnology sectors, including leading the development of a therapeutic cancer vaccine.
Education and Expertise of Angelos M. Stergiou
Angelos M. Stergiou holds a Doctor of Medicine from the U.S. American Institute of Medicine. He received a Doctor of Science (honoris causa) degree from Kentucky Wesleyan College. Stergiou completed his undergraduate degree in pre-medicine, biology, and chemistry at Kentucky Wesleyan College. His educational background is complemented by his accreditation as a Fellow of the Royal Society of Medicine in the UK. He is also actively involved in the World Medical Association, the American Academy of Physicians in Clinical Research, and the Association of Clinical Research Professionals.
Professional Background of Angelos M. Stergiou
Angelos M. Stergiou has held various global positions of increasing responsibility in the pharmaceutical and biotechnology sectors. From 2002 to 2009, he was involved with companies such as PAION AG, Accentia Biopharmaceuticals, BioVest International, Analytica International, and Anavex Life Sciences. He has significant experience leading clinical development projects, notably steering the Phase 3 development of the therapeutic cancer vaccine BiovaxID. This project was presented at the American Society of Clinical Oncology plenary session in 2009, and Stergiou holds a patent on the technology.
Roles and Contributions in Biotechnology
Angelos M. Stergiou currently serves on the Board of Directors of Cleara Biotech B.V., a biotech company located in the Netherlands, since January 2022. He co-founded Genesis Life Sciences, Ltd. (now Genesis Research) and served as its President and Chief Operating Officer from 2009 to 2011. His contributions to the biotechnology field span across various roles and companies, where he has significantly influenced health economics, pricing-reimbursement strategies, and health access.
Leadership and Board Memberships
Among his leadership roles, Angelos M. Stergiou served as a member of the Board of Trustees at Kentucky Wesleyan College from March 2017 to January 2021. His board memberships extend to significant biotechnology firms, such as his ongoing role with Cleara Biotech B.V. Since co-founding Genesis Life Sciences, he has continually held high-responsibility positions, enhancing his leadership profile in the industry.